Mantoux test

WikiDoc Resources for Mantoux test
Articles
Most recent articles on Mantoux test Most cited articles on Mantoux test Review articles on Mantoux test Articles on Mantoux test in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Mantoux test Images of Mantoux test Photos of Mantoux test Podcasts & MP3s on Mantoux test Videos on Mantoux test
Evidence Based Medicine
Cochrane Collaboration on Mantoux test Bandolier on Mantoux test TRIP on Mantoux test
Clinical Trials
Ongoing Trials on Mantoux test at Clinical Trials.gov Trial results on Mantoux test Clinical Trials on Mantoux test at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Mantoux test NICE Guidance on Mantoux test NHS PRODIGY Guidance FDA on Mantoux test CDC on Mantoux test
Books
Books on Mantoux test
News
Mantoux test in the news Be alerted to news on Mantoux test News trends on Mantoux test
Commentary
Blogs on Mantoux test
Definitions
Definitions of Mantoux test
Patient Resources / Community
Patient resources on Mantoux test Discussion groups on Mantoux test Patient Handouts on Mantoux test Directions to Hospitals Treating Mantoux test Risk calculators and risk factors for Mantoux test
Healthcare Provider Resources
Symptoms of Mantoux test Causes & Risk Factors for Mantoux test Diagnostic studies for Mantoux test Treatment of Mantoux test
Continuing Medical Education (CME)
CME Programs on Mantoux test
International
Mantoux test en Espanol Mantoux test en Francais
Business
Mantoux test in the Marketplace Patents on Mantoux test
Experimental / Informatics
List of terms related to Mantoux test

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]

Synonyms and keywords: PPD, TB skin test, TST, tst

Overview

The Mantoux tuberculin skin test (TST) is the standard method of determining whether a person is infected with Mycobacterium tuberculosis. Reliable administration and reading of the TST requires standardization of procedures, training, supervision, and practice.

Procedure

The TST is performed by injecting 0.1 ml of tuberculin purified protein derivative (PPD) into the inner surface of the forearm. The injection should be made with a tuberculin syringe, with the needle bevel facing upward. The TST is an intradermal injection. When placed correctly, the injection should produce a pale elevation of the skin (a wheal) 6 to 10 mm in diameter.

The skin test reaction should be read between 48 and 72 hours after administration. A patient who does not return within 72 hours will need to be rescheduled for another skin test.

The reaction should be measured in millimeters of the induration (palpable, raised, hardened area or swelling). The reader should not measure erythema (redness). The diameter of the indurated area should be measured across the forearm (perpendicular to the long axis).

Classification of Tuberculin Reaction

Skin test interpretation depends on two factors:

• Measurement in millimeters of the induration.
• Person’s risk of being infected with TB and of progression to disease if infected.

Image from Public Health Image Library (PHIL) Image from Public Health Image Library (PHIL)

Tuberculin Reaction	Considered a Positive Result in:
≥ 5 mm	HIV-positive person Recent contacts of TB case Persons with nodular or fibrotic changes on CXR consistent with old healed TB Patients with organ transplants and other immunosuppressed patients
≥ 10 mm	Recent arrivals (less than 5 years) from high-prevalent countries Injection drug users Residents and employees of high-risk congregate settings (e.g., prisons, nursing homes, hospitals, homeless shelters) Mycobacteriology lab personnel Persons with clinical conditions that place them at high risk (e.g., diabetes, prolonged corticosteroid therapy, leukemia, end-stage renal disease, chronic malabsorption syndromes, low body weight) Children less than 4 years of age, or children and adolescents exposed to adults in high-risk categories
≥ 15 mm	Persons with no known risk factors for TB
Table adapted from CDC

Contraindications

TST is contraindicated only for persons who have had a severe reaction (e.g., necrosis, blistering, anaphylactic shock, or ulcerations) to a previous TST. It is not contraindicated for any other persons, including infants, children, pregnant women, persons who are HIV-infected, or persons who have been vaccinated with BCG.

False-Poisitve and False-Negative Reactions

In some persons who are infected with M. tuberculosis, the ability to react to tuberculin may wane over time. When given a TST years after infection, these persons may have a false-negative reaction. However, the TST may stimulate the immune system, causing a positive, or boosted reaction to subsequent tests. Giving a second TST after an initial negative TST reaction is called two-step testing.

False-Positive Reactions	False-Negative Reactions
Some persons may react to the TST even though they are not infected with M. tuberculosis. The causes of these false-positive reactions may include, but are not limited to, the following: Infection with nontuberculosis mycobacteria Previous BCG vaccination Incorrect method of TST administration Incorrect interpretation of reaction Incorrect bottle of antigen used	Some persons may not react to the TST even though they are infected with M. tuberculosis. The reasons for these false-negative reactions may include, but are not limited to, the following: Cutaneous anergy (anergy is the inability to react to skin tests because of a weakened immune system) Recent TB infection (within 8-10 weeks of exposure) Very old TB infection (many years) Very young age (less than 6 months old) Recent live-virus vaccination (e.g., measles and smallpox) Overwhelming TB disease Some viral illnesses (e.g., measles and chicken pox) Incorrect method of TST administration Incorrect interpretation of reaction
Table adapted from CDC

Two-step Testing

Two-step testing is useful for the initial skin testing of adults who are going to be retested periodically, such as health care workers or nursing home residents. This two-step approach can reduce the likelihood that a boosted reaction to a subsequent TST will be misinterpreted as a recent infection.

See also

• Mycobacterium tuberculosis
• Tuberculosis
• Latent tuberculosis
• Tine test